Menu Search
Equities

Mesa Laboratories Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MLI:MUN

Mesa Laboratories Inc

Actions
  • Price (EUR)76.00
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-45.71%
  • Beta0.8484
Data delayed at least 15 minutes, as of Feb 17 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Mesa Laboratories Inc grew revenues 11.47% from 216.19m to 240.98m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -254.25m to -1.97m.
Gross margin62.40%
Net profit margin1.51%
Operating margin6.96%
Return on assets0.86%
Return on equity2.18%
Return on investment1.13%
More ▼

Cash flow in USDView more

In 2025, Mesa Laboratories Inc did not generate a significant amount of cash. However, the company earned 46.81m from its operations for a Cash Flow Margin of 19.42%. In addition the company used 4.50m on investing activities and also paid 44.51m in financing cash flows.
Cash flow per share5.20
Price/Cash flow per share17.41
Book value per share33.79
Tangible book value per share-16.70
More ▼

Balance sheet in USDView more

Mesa Laboratories Inc has a Debt to Total Capital ratio of 47.09%, a lower figure than the previous year's 61.08%.
Current ratio1.94
Quick ratio1.45
Total debt/total equity0.8899
Total debt/total capital0.4709
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)0.35%
Div growth rate (5 year)0.00%
Payout ratio (TTM)93.97%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		101.40
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.